Healthcare Experience

Brand Institute Healthcare Share of Market


Our Healthcare experience includes 610 clients, with 2,421 partnered brands and 503 USAN/INN names. Below is our extensive portfolio, feel free to filter by clients, brands, category or USAN/INN Names.   ||  Click Here for Consumer/B2B Experience



CLIENTS BRANDS CATEGORY
FABRE KRAMER PHARMACEUTICALS TRAVIVO Neurology
FAMY CARE ESME 21 Women's Health
FAMY CARE ESME 28 Women's Health
FAMY CARE INDAYO Women's Health
FAMY CARE CONTINGENCY ONE Women's Health
FERRING PHARMACEUTICALS merotocin Women's Health
FERRING PHARMACEUTICALS follitropin delta Women's Health
FERRING PHARMACEUTICALS CORTIMENT * Gastrointestinal
FERRING PHARMACEUTICALS SEPSIS-ACT Clinical Trial Name
FERRING PHARMACEUTICALS PREPOPIK Gastrointestinal
FERX MAGNETARG Medical Device
FIBROGEN roxadustat Nephrology
FIBROGEN pamrevlumab Immunology
FIVE PRIME THERAPEUTICS cabiralizumab Oncology
FORBES MEDI-TECH FORBES MEDI-TECH Corporate Identity
FOREST LABORATORIES SAVELLA Women's Health
FOREST LABORATORIES CAMPRAL Neurology
FOREST LABORATORIES CELEXA Neurology
FOREST LABORATORIES NAMENDA Neurology
FOREST LABORATORIES NAMENDA XR Neurology
FOREST LABORATORIES TEFLARO Antibiotic
FOREST LABORATORIES DALIRESP Respiratory
FOREST LABORATORIES CONSTELLA * Gastrointestinal
FOREST LABORATORIES LINZESS Gastrointestinal
FOREST LABORATORIES AVYCAZ Antibiotic
FOREST LABORATORIES VIIBRYD * Neurology
FOREST LABORATORIES BYSTOLIC * Cardiovascular
FOREST LABORATORIES NAMZARIC Neurology
FORUM PHARMACEUTICALS encenicline Neurology
FREEDOM INNOVATIONS KINTERRA Medical Device
FRESENIUS PHOSLYRA * Nephrology
FRESENIUS-KABI KABIVEN Nutritional Agent


* Denotes a comprehensive report of the safety regulatory research prepared by BI/DSI for submission of this name candidate to FDA and/or EMA, and/or Health Canada, and other Regulatory Agencies.

Back to top